The Office of Research and Development has a PhD scholarship available for Honours/MSc students with knowledge and skills in cellular/molecular biology and pharmacology.
This project is suitable for students with keen interest in cancer research. The high morbidity and mortality in many types of human cancer is often attributed to cancer cells that are refractory to conventional therapies, and thus clonally develop into recurrent tumours. The aims of this project is to understand the etiology of drug resistance in tumours, and to develop strategic sensitizing therapies and predictive biomarkers for refractory cancers. The ultimate goal is to reduce number of cancer recurrences and improve outcome of therapy.
Applications accepted at any time
The successful candidate will receive an annual stipend of $26,682 (2017) tax-free which will be indexed annually for the duration of the award. The scholarship will be for three years with a maximum of possible extension of up to six months.
The tuition fees for a domestic candidate shall be covered by the Research Training Program (RTP).
Honours 1 in Medical Science, Biomedical Science, Pharmacy or related;
Master by Research in Medical Science, Biomedical Science, Pharmacy or related